Burn Spray
- Manufacturer
- HART Health | Nantong Health & Beyond Hygienic Products Inc.
- Effective date
- 2025-08-15
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 01:14:06
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients:
Lidocaine HCL 2%
OTC - PURPOSE SECTION
Purpose:
Topical Anesthetic
INDICATIONS & USAGE SECTION
Uses:
Temporary pain relief of minor burns
WARNINGS SECTION
Warnings
For external use only
See a doctor immediately or serious burns
OTC - DO NOT USE SECTION
Do not use
- in or near the eyes
- over large portions of the body
- in large quantities particularly over raw surfaces or blistered areas
- on serious burns
- longer than 7 days unless directed by a doctor
- on animal bites
- on deep or puncture wounds
OTC - STOP USE SECTION
Stop use and ask a doctor if
- condition lasts for more than 7 days
- condition worsens
- symptoms clear up and occur again within a few days
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away. 1-800-222-1222
DOSAGE & ADMINISTRATION SECTION
Directions:
Adults and children 2 years of age and over:
- clean the affected area
- apply to the affected area not more than 3 to 4 times dailys
- may be covered with a sterile bandage when dry
Children under 2 years of age: ask a doctor
OTHER SAFETY INFORMATION
store at 68° to 77°F (20-25°C)
INACTIVE INGREDIENT SECTION
Inactive Ingredients
aminomethyl propanol, glycerin, hydroxypropyl methylcellulose, melaleuca alterniflia (tea tree) leaf oil, octoxynol 9, PEG-40 hydrogenated castor oil, phenoxyethanol, propylene glycol, water
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50332-0209-1 | Burn | 59 mL in 1 BOTTLE, SPRAY | SPRAY | 59 | 1 |
Products#
Every source-derived product name is available through these pages.
- Burn
- Lidocaine
- LIDOCAINE HYDROCHLORIDE
- AMINOMETHYL PROPANOL
- GLYCERIN
- HYDROXYPROPYL METHYLCELLULOSE
- MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL
- OCTOXYNOL 9
- PEG-40 HYDROGENATED CASTOR OIL
- PHENOXYETHANOL
- PROPYLENE GLYCOL
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 50332-0209 | 50332-0209-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LIDOCAINE HYDROCHLORIDE | V13007Z41A | ACTIR |
| AMINOMETHYL PROPANOL | LU49E6626Q | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| HYDROXYPROPYL METHYLCELLULOSE | 3NXW29V3WO | IACT |
| MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL | VIF565UC2G | IACT |
| OCTOXYNOL 9 | 7JPC6Y25QS | IACT |
| PEG-40 HYDROGENATED CASTOR OIL | 7YC686GQ8F | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Burn | LIDOCAINE | HART Health | c5ff392a-e788-43e0-91ea-5e0f8420586c | 2025-08-15 | Warnings | 50332-0209-1 50332-0209 50332020901 8dfa2b7a-8953-4f4b-be02-a28f9a27071e c5ff392a-e788-43e0-91ea-5e0f8420586c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
